BEN-MAIMON CAROLE bought LRMR

November 11, 2026 · Form 4 insider transaction

BEN-MAIMON CAROLE bought 18,050 shares of Larimar Therapeutics, Inc. at $2.77 per share, a transaction worth $50.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
18,050
Price
$2.77
Total value
$50.0K
RoleOfficer, Director
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 11, 2026
Filing dateNovember 12, 2026
Shares owned after386,326
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.; The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.765 to $2.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

View the original Form 4 on SEC EDGAR